Sugi Predict

Sugi Predict / Compounds / SCHEMBL29720231

SCHEMBL29720231

SCHEMBL29720231

C[Sn](C)(C)c1cccc2cnccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.53
▸ LMNA P02545 4/20 0.53
▸ CYP3A4 P08684 3/20 0.53
▸ CYP2D6 P10635 3/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ MAPKAPK2 P49137 1/20 0.53
▸ HTT P42858 1/20 0.49
▸ ALDH1A1 P00352 6/20 0.41
▸ MAPT P10636 6/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ ROCK2 O75116 2/20 0.41
▸ ROCK1 Q13464 2/20 0.41
▸ PRKD3 O94806 2/20 0.40
▸ PRKCG P05129 2/20 0.40
▸ PRKCB P05771 2/20 0.40
▸ PRKCA P17252 2/20 0.40
▸ NFKB1 P19838 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15941363 1.00 KDM4E (0.53) KDM4ELMNACYP3A4CYP2D6CYP1A2
SCHEMBL4042299 0.76 PRKCZ (0.42) KDM4ELMNACYP3A4CYP2D6CYP1A2
SCHEMBL691687 0.75 LMNA (0.49) KDM4ELMNACYP3A4CYP2D6CYP1A2
SCHEMBL5952012 0.74 ALDH1A1 (0.48) CYP3A4CYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL12271 0.74 KDM4E (0.59) KDM4ELMNACYP3A4CYP2D6CYP1A2
SCHEMBL6240424 0.73 LMNA (0.63) KDM4ELMNACYP3A4CYP2D6CYP1A2
SCHEMBL30150751 0.72 KDM4E (0.57) KDM4ELMNACYP3A4CYP2D6CYP1A2
SCHEMBL7948611 0.71 KDM4E (0.61) KDM4ELMNACYP3A4CYP2D6CYP1A2
SCHEMBL3805113 0.69 CYP1A2 (0.59) KDM4ELMNACYP3A4CYP2D6CYP1A2
SCHEMBL4207818 0.69 KDM4E (0.59) KDM4ELMNACYP3A4CYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552830-B2 Steroidal compound derivatives as therapeutic agents UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2026-02-17 — — US disclosed
US-20240376145-A9 STEROIDAL COMPOUND DERIVATIVES AS THERAPEUTIC AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2024-11-14 — — US disclosed
US-20240083936-A1 STEROIDAL COMPOUND DERIVATIVES AS THERAPEUTIC AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2024-03-14 — — US disclosed
WO-2022133265-A1 STEROIDAL COMPOUND DERIVATIVES AS THERAPEUTIC AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORTED (US) 2022-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240083936-A1 STEROIDAL COMPOUND DERIVATIVES AS THERAPEUTIC AGENTS PGF, HPGDS, NR5A1 KDM4E 4255/4885LMNA 3063/4885CYP3A4 1242/4885
US-12552830-B2 Steroidal compound derivatives as therapeutic agents PGF, NR3C2, NR5A1 KDM4E 3882/4885LMNA 1575/4885CYP3A4 738/4885
US-20240376145-A9 STEROIDAL COMPOUND DERIVATIVES AS THERAPEUTIC AGENTS PGF, HPGDS, NR5A1 KDM4E 4255/4885LMNA 3063/4885CYP3A4 1242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.